Invention Grant
- Patent Title: Anti-CD40 antibodies
-
Application No.: US15384003Application Date: 2016-12-19
-
Publication No.: US11001637B2Publication Date: 2021-05-11
- Inventor: Yongke Zhang , Guo-Liang Yu , Weimin Zhu
- Applicant: Apexigen, Inc.
- Applicant Address: US CA San Carlos
- Assignee: Apexigen, Inc.
- Current Assignee: Apexigen, Inc.
- Current Assignee Address: US CA San Carlos
- Agency: Cooley LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61P35/00 ; A61K39/00
Abstract:
The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
Public/Granted literature
- US20170233483A1 ANTI-CD40 ANTIBODIES AND METHODS OF USE Public/Granted day:2017-08-17
Information query
